| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.41▲ | 0.41▲ | 0.41▲ | 0.43▼ | 0.43▼ |
| MA10 | 0.41▲ | 0.41▲ | 0.41▲ | 0.44▼ | 0.48▼ |
| MA20 | 0.41▼ | 0.42▼ | 0.42▼ | 0.44▼ | 0.60▼ |
| MA50 | 0.44▼ | 0.44▼ | 0.44▼ | 0.50▼ | 1.26▼ |
| MA100 | 0.44▼ | 0.43▼ | 0.43▼ | 0.61▼ | 1.93▼ |
| MA200 | 0.43▼ | 0.44▼ | 0.45▼ | 1.05▼ | 14.50▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.000▲ | -0.001▼ | 0.002▲ | 0.024▲ |
| RSI | 42.030▼ | 39.547▼ | 38.925▼ | 38.319▼ | 33.122▼ |
| STOCH | 48.007 | 46.319 | 33.887 | 37.502 | 10.973▼ |
| WILL %R | -45.912 | -47.239 | -81.304▼ | -90.727▼ | -96.869▼ |
| CCI | 32.675 | 7.587 | -32.508 | -113.988▼ | -77.748 |
|
Friday, March 20, 2026 06:56 AM
GT Biopharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of the immuno-oncology therapeutic products based proprietary TriKE NK cell engager ...
|
|
Monday, February 16, 2026 11:30 PM
SAN FRANCISCO, CALIFORNIA, Feb. 17, 2026 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics ...
|
|
Friday, January 16, 2026 06:22 AM
The MarketWatch News Department was not involved in the creation of this content. Issued on behalf of GT Biopharma, Inc. VANCOUVER, BC, Jan. 16, 2026 /PRNewswire/ -- Equity Insider News Commentary -- ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 31/03/26 | 0.4002 | 0.4103 | 0.4002 | 0.4088 | 365,526 |
| 30/03/26 | 0.40 | 0.4221 | 0.40 | 0.4143 | 409,164 |
| 27/03/26 | 0.4401 | 0.4499 | 0.40 | 0.4089 | 1,124,935 |
| 26/03/26 | 0.4623 | 0.4623 | 0.4417 | 0.446 | 406,113 |
| 25/03/26 | 0.47 | 0.47 | 0.4511 | 0.465 | 370,969 |
| 24/03/26 | 0.4685 | 0.4949 | 0.4558 | 0.4751 | 1,026,173 |
| 23/03/26 | 0.4426 | 0.4732 | 0.4418 | 0.4685 | 743,002 |
| 20/03/26 | 0.4303 | 0.4601 | 0.42 | 0.4601 | 1,629,166 |
| 19/03/26 | 0.4573 | 0.4599 | 0.4166 | 0.4254 | 553,140 |
| 18/03/26 | 0.43 | 0.435 | 0.42 | 0.429 | 205,300 |
|
|
||||
|
|
||||
|
|